Arno Mohr1, Michaela Simon2, Tobias Joha3, Frank Hanses4, Bernd Salzberger3, Florian Hitzenbichler3. 1. Infectious Diseases Unit, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany. arno.mohr@ukr.de. 2. Institute for Clinical Microbiology and Hygiene, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany. 3. Infectious Diseases Unit, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany. 4. Emergency Department, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
Abstract
BACKGROUND: The aim of this study was to analyse temporal changes in the epidemiology of candidemia assessing patient's characteristics, risk factors, diagnostic management, treatment, and outcome in a tertiary care hospital in South Eastern Germany. METHODS: In this retrospective cohort study patients with blood cultures positive for Candida spp. were identified from the microbiological database in the years 2006-2018. A detailed collection of patients' characteristics was obtained for the time periods 2006-2008 and 2016-2018. Risk factors for survival were analysed in a logistic regression analysis. RESULTS: In the years 2006-2018, a total of 465 episodes of candidemia were identified. An increase in candidemia cases was evident in the period of 2016-2018 compared to 2006-2015 and to 2006-2008 in absolute numbers and adjusted to patient-days. C. albicans was responsible for 62.8% of cases in 2006-2008 and 51.2% of all cases in the years 2016-2018, respectively, whereas there was a significant increase of C. glabrata in the latter period (16.3-31.5%). Overall mortality was not significantly different in the two periods. Infectious diseases consultation led to a lower mortality of patients with candidemia and to a higher adherence to guidelines. In multivariate analysis, only complete change or extraction of intravascular indwelling material and female gender were independent predictors for survival. CONCLUSION: We observed an increase in candidemia rates and rates of non-albicans spp. over time. A complete change of all catheters and/or indwelling devices improved survival. ID consultation led to a better guideline adherence.
BACKGROUND: The aim of this study was to analyse temporal changes in the epidemiology of candidemia assessing patient's characteristics, risk factors, diagnostic management, treatment, and outcome in a tertiary care hospital in South Eastern Germany. METHODS: In this retrospective cohort study patients with blood cultures positive for Candida spp. were identified from the microbiological database in the years 2006-2018. A detailed collection of patients' characteristics was obtained for the time periods 2006-2008 and 2016-2018. Risk factors for survival were analysed in a logistic regression analysis. RESULTS: In the years 2006-2018, a total of 465 episodes of candidemia were identified. An increase in candidemia cases was evident in the period of 2016-2018 compared to 2006-2015 and to 2006-2008 in absolute numbers and adjusted to patient-days. C. albicans was responsible for 62.8% of cases in 2006-2008 and 51.2% of all cases in the years 2016-2018, respectively, whereas there was a significant increase of C. glabrata in the latter period (16.3-31.5%). Overall mortality was not significantly different in the two periods. Infectious diseases consultation led to a lower mortality of patients with candidemia and to a higher adherence to guidelines. In multivariate analysis, only complete change or extraction of intravascular indwelling material and female gender were independent predictors for survival. CONCLUSION: We observed an increase in candidemia rates and rates of non-albicansspp. over time. A complete change of all catheters and/or indwelling devices improved survival. ID consultation led to a better guideline adherence.
Entities:
Keywords:
Candida spp.; Candidemia; Epidemiology; ID consultation
Authors: Peter G Pappas; John H Rex; Jack D Sobel; Scott G Filler; William E Dismukes; Thomas J Walsh; John E Edwards Journal: Clin Infect Dis Date: 2003-12-19 Impact factor: 9.079
Authors: O A Cornely; M Bassetti; T Calandra; J Garbino; B J Kullberg; O Lortholary; W Meersseman; M Akova; M C Arendrup; S Arikan-Akdagli; J Bille; E Castagnola; M Cuenca-Estrella; J P Donnelly; A H Groll; R Herbrecht; W W Hope; H E Jensen; C Lass-Flörl; G Petrikkos; M D Richardson; E Roilides; P E Verweij; C Viscoli; A J Ullmann Journal: Clin Microbiol Infect Date: 2012-12 Impact factor: 8.067
Authors: H M Blumberg; W R Jarvis; J M Soucie; J E Edwards; J E Patterson; M A Pfaller; M S Rangel-Frausto; M G Rinaldi; L Saiman; R T Wiblin; R P Wenzel Journal: Clin Infect Dis Date: 2001-06-20 Impact factor: 9.079
Authors: Travis M Jones; Richard H Drew; Dustin T Wilson; Christina Sarubbi; Deverick J Anderson Journal: Am J Health Syst Pharm Date: 2017-12-01 Impact factor: 2.637
Authors: Jennifer K Chow; Yoav Golan; Robin Ruthazer; Adolf W Karchmer; Yehuda Carmeli; Deborah A Lichtenberg; Varun Chawla; Janet A Young; Susan Hadley Journal: Crit Care Med Date: 2008-07 Impact factor: 7.598
Authors: Takaaki Kobayashi; Alexandre R Marra; Marin L Schweizer; Patrick Ten Eyck; Chaorong Wu; Mohammed Alzunitan; Jorge L Salinas; Marc Siegel; Dimitrios Farmakiotis; Paul G Auwaerter; Heather S Healy; Daniel J Diekema Journal: Open Forum Infect Dis Date: 2020-08-03 Impact factor: 3.835
Authors: Patrick Schwarz; Ilya Nikolskiy; Anne-Laure Bidaud; Frank Sommer; Gert Bange; Eric Dannaoui Journal: Front Cell Infect Microbiol Date: 2022-04-29 Impact factor: 6.073